A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysisArticle Published on 2023-02-132023-06-11 Journal: Nephrology, dialysis, transplantation : official p [Category] B형 간염, [키워드] dialysis Hepatitis B vaccination HepB (Engerix) HepB-CpG (Heplisav B) seroprotection. [DOI] 10.1093/ndt/gfac039 PMC 바로가기
The vulnerability of maintenance dialysis patients with COVID-19: mortality and risk factors from a developing countryObservational Study Published on 2022-12-012022-10-04 Journal: Annals of Medicine [Category] 임상, [키워드] age Blood Group Characteristics Clinical features collected data complications country COVID-19 death demographics diabetes dialysis epidemiological Factor General population Haemodialysis hospitalisation ICU admission implementation incidence incidence of COVID-19 increased risk independent risk factor infected patient Infection infection control intensive care intubation Male sex measure Measures Mortality mortality rate mortality rate; multivariable logistic regression old age outcomes Patient patients Peritoneal dialysis peritoneal dialysis. positive Predictive reduce required retrospective risk risk factor risk of infection significantly significantly increased smoking study period tested therapy Vascular venous catheter was used West Bank [DOI] 10.1080/07853890.2022.2075914 PMC 바로가기 [Article Type] Observational Study
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsArticle Published on 2022-10-062022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제, [키워드] ACE2 binding addition administration analysed anti-RBD B.1 binding BNT162b2 boost immunity cellular Control controls COVID-19 COVID-19 vaccination Decline declining Delta detectable dialysis dose doses group Haemodialysis Haemodialysis patient humoral humoral immune response Humoral immunity IgG IgG response immune immune evasion immune protection immunoassays Immunocompromised individual individuals information interferon γ knowledge longitudinal longitudinal response maintain mixed mRNA vaccination mRNA mRNA vaccination mRNA-1273 mucosal omicron Omicron variant of concern Patient patients Prevent protective immunity protective immunity. RBD reached regimen remained respond poorly restored SARS-CoV-2 vaccination SARS-CoV-2 variant second vaccination severe COVID-19 significantly increased spike subsequent Support T-cell Response tested the receptor-binding domain vaccination Vaccine variant variants of concern [DOI] 10.3389/fimmu.2022.1004045 PMC 바로가기
SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodiesSARS-CoV-2 mRNA 백신 접종은 항-HLA 또는 비-HLA 항체의 유도와 관련이 없습니다Article Published on 2022-10-012022-09-11 Journal: Transplant immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] antibodies antibody ARHGDIB association BNT162b2 Clinical significance clinically Control debate detectable dialysis elevated evaluated first dose Haemodialysis HLA human leukocyte antigen Human leukocyte antigen (HLA) induce kidney kidney transplant recipient kidney transplant recipients leukocyte matter minor Minor antigen mRNA mRNA BNT162b2 mRNA vaccination mRNA vaccine mRNA-1273 mRNA-1273 vaccine Patient patients Peritoneal dialysis positive profile proportion SARS-CoV-2 SARS-CoV-2 vaccination the SARS-CoV-2 Trigger vaccination vaccination. vaccine dose [DOI] 10.1016/j.trim.2022.101670 PMC 바로가기 [Article Type] Article
Newly-diagnosed immunoglobulin A nephropathy with increased plasma galactose-deficient-IgA1 antibody associated with mRNA COVID-19 vaccination: a case reportArticle Published on 2022-10-012022-11-15 Journal: The Journal of international medical research [Category] 진단, [키워드] Activation Acute kidney injury Admission antibody Case report characterized clinical disease COVID-19 COVID-19 vaccination dialysis elevated Encephalopathy exacerbating first dose galactose-deficient IgA1 Haemodialysis IgA nephropathy immunoglobulin A immunoglobulin A nephropathy. Immunosuppressive treatment kidney male Mental Mild MOST mRNA mRNA-1273 COVID-19 vaccine nephropathy Patient plasma receive receiving renal biopsy renal function reported Treatment vaccination with COVID-19 [DOI] 10.1177/03000605221129674 PMC 바로가기
Impact of variant of concern and vaccination status on COVID-19 infection virological dynamics in end stage kidney disease patients receiving haemodialysisArticle Published on 2022-10-012022-11-16 Journal: Nephrology (Carlton, Vic.) [Category] COVID19(2023년), SARS, 변종, [키워드] Affect Cohort COVID-19 COVID-19 illness COVID-19 infection De-isolation dialysis Haemodialysis Impact inactive individual Infection Kidney disease Negative PCR Observational cohort study Patient PCR cycle PCR-confirmed COVID-19 performed polymerase chain prolonged viral shedding protocol receiving required retrospective subject Swab threshold value time vaccination variant variant of concern variants Viral load Virological virus virus shedding. [DOI] 10.1111/nep.14084 PMC 바로가기
Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreakArticle Published on 2022-10-012022-11-16 Journal: American journal of infection control [Category] COVID19(2023년), SARS, 변종, [키워드] affected attack Care Cluster complications COVID19 demonstrated diagnosed diagnostic dialysis disease incidence effective Effectiveness effort Epidemiology ESRD Genomics greater help Hemodialysis Infection infection control Infection prevention Intervention measure Measures mitigate morbidity Nosocomial transmission outbreak Patient patients positive protective effect provided receiving reducing risk robust RT-PCR SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 genome sequence SARS-COV-2 infection specimens Support Transmission vaccination Viral epidemiology. Viral genome sequencing while [DOI] 10.1016/j.ajic.2022.06.025 PMC 바로가기
Multiple Post-SARS-COV2 Infectious Complications in Kidney Transplant RecipientArticle Published on 2022-09-292022-11-15 Journal: Medicina [Category] SARS, 진단, [키워드] Candida Clostridioides difficile infection Complication Course COVID-19 infection diagnosed dialysis disease glomerular filtration rate Hemodialysis hospital Hospitalization Infection infections kidney Kidney transplantation Klebsiella pneumoniae Mild Modification multi-pathogenic infections. multiorgan failure Multiple neutralizing antibody occurred oral candidiasis Patient recipient required SARS-CoV-2 SARS-COV-2 infection Severe infection Streptococcus the disease the patient therapy Transplant Urinary tract vaccinated against COVID-19 [DOI] 10.3390/medicina58101370 PMC 바로가기
Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort studyArticle Published on 2022-09-222022-11-16 Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 변종, [키워드] adjusted Admissions age analyzed clinical epidemiology cohort study Comorbidity Course COVID-19 Cox proportional hazard dialysis died disease severity dissemination dominant dose doses driven by Efficacy first dose Hemodialysis high risk Hospitalized incidence Infection information less majority Mild observation period omicron Patient positive predictor variable provided reducing reduction in Regression model risk SARS-CoV-2 SARS-COV-2 infection second dose Severity of infection the epidemic vaccination vaccination. Vaccine vaccine doses variant [DOI] 10.1093/ndt/gfac209 PMC 바로가기
Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and PakistanArticle Published on 2022-09-082022-11-16 Journal: BMC Nephrology [Category] SARS, 치료기술, [키워드] Acute kidney injury age AKI analysed Cohort collected Continuous Continuous renal replacement therapy COVID 19 patient COVID-19 COVID-19 infected patient Critically ill Critically ill patient critically ill patients detect dialysis died Efficiency form Hemodialysis high mortality hospital ICU India kidney Kidney injury laboratory parameter men Mortality outcome pandemic Patient patients died patients with COVID-19 renal renal replacement therapy required RRT serum albumin slow Slow low efficiency dialysis. the mean therapeutic intervention variable ventilatory support [DOI] 10.1186/s12882-022-02931-3 PMC 바로가기